Consuelo Micheli , Ana Rita Oliveira , Beatriz Millán , Marcos Cardoso , Marta Araújo , Cláudio Duarte-Oliveira , Ana Mendes-Frias , Ricardo Silvestre , Cristina Cunha , Agostinho Carvalho , Fernando Rodrigues , Manuel Vilanova , África González-Fernández , António G. Castro , Egídio Torrado
{"title":"Alveolar macrophages shape tuberculosis susceptibility by delaying protective immunity","authors":"Consuelo Micheli , Ana Rita Oliveira , Beatriz Millán , Marcos Cardoso , Marta Araújo , Cláudio Duarte-Oliveira , Ana Mendes-Frias , Ricardo Silvestre , Cristina Cunha , Agostinho Carvalho , Fernando Rodrigues , Manuel Vilanova , África González-Fernández , António G. Castro , Egídio Torrado","doi":"10.1016/j.mucimm.2026.02.006","DOIUrl":null,"url":null,"abstract":"<div><div>Effective control of <em>Mycobacterium tuberculosis</em> (Mtb) infection requires timely activation and accumulation of CD4<sup>+</sup> T cells in the lungs, yet the factors delaying this response remain unclear. Here we show that alveolar macrophages (AMs) delay CD4<sup>+</sup> T cell priming by retaining Mtb within the alveolar lumen, limiting other myeloid cells access to the bacteria. This defect is more pronounced in susceptible C3HeB/FeJ mice than in C57BL/6 mice and arises from reduced IL-1β and GM-CSF production, which impair the migration of AMs to the lung parenchyma. Targeting AMs accelerates the activation of the adaptive immune response but fails to promote bacterial control over the chronic phase of infection due to neutrophils interference on CD4<sup>+</sup> T cell function. Crucially, sequential depletion of AMs and neutrophils restores CD4<sup>+</sup> T cell function and enhances infection control. These findings uncover a novel bottleneck in tuberculosis immunity and suggest that targeting AMs may accelerate adaptive immunity but overcoming local inflammatory constraints may be necessary to sustain infection control.</div></div>","PeriodicalId":18877,"journal":{"name":"Mucosal Immunology","volume":"19 3","pages":"Article 100325"},"PeriodicalIF":5.5000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mucosal Immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1933021926000231","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/21 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Effective control of Mycobacterium tuberculosis (Mtb) infection requires timely activation and accumulation of CD4+ T cells in the lungs, yet the factors delaying this response remain unclear. Here we show that alveolar macrophages (AMs) delay CD4+ T cell priming by retaining Mtb within the alveolar lumen, limiting other myeloid cells access to the bacteria. This defect is more pronounced in susceptible C3HeB/FeJ mice than in C57BL/6 mice and arises from reduced IL-1β and GM-CSF production, which impair the migration of AMs to the lung parenchyma. Targeting AMs accelerates the activation of the adaptive immune response but fails to promote bacterial control over the chronic phase of infection due to neutrophils interference on CD4+ T cell function. Crucially, sequential depletion of AMs and neutrophils restores CD4+ T cell function and enhances infection control. These findings uncover a novel bottleneck in tuberculosis immunity and suggest that targeting AMs may accelerate adaptive immunity but overcoming local inflammatory constraints may be necessary to sustain infection control.
期刊介绍:
Mucosal Immunology, the official publication of the Society of Mucosal Immunology (SMI), serves as a forum for both basic and clinical scientists to discuss immunity and inflammation involving mucosal tissues. It covers gastrointestinal, pulmonary, nasopharyngeal, oral, ocular, and genitourinary immunology through original research articles, scholarly reviews, commentaries, editorials, and letters. The journal gives equal consideration to basic, translational, and clinical studies and also serves as a primary communication channel for the SMI governing board and its members, featuring society news, meeting announcements, policy discussions, and job/training opportunities advertisements.